Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation

BACKGROUND: Serum levels of IGF-I in patients affected with multiple myeloma (MM) have been scarcely studied. The present study is aimed to explore this point comparing 55 healthy subjects, 71 monoclonal gammopaties of uncertain significance (MGUS) and 77 overt MM patients. In the same subjects, bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Greco, Claudia, Vitelli, Gaetano, Vercillo, Giuseppe, Vona, Rosa, Giannarelli, Diana, Sperduti, Isabella, Pisani, Francesco, Capoluongo, Ettore, Petti, Maria Concetta, Ameglio, Franco
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663546/
https://www.ncbi.nlm.nih.gov/pubmed/19284554
http://dx.doi.org/10.1186/1756-9966-28-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663546/
https://www.ncbi.nlm.nih.gov/pubmed/19284554
http://dx.doi.org/10.1186/1756-9966-28-35

Ejemplares similares